small cell lung cancer
German Initiative Making Headway in Improving Lung Cancer Patients' Precision Oncology Access
Premium
The national Network Genomic Medicine Lung Cancer is focused on facilitating molecular profiling-informed treatment to NSCLC patients across 28 partner hospitals in the country.
Lung Cancer Progression, Prognostic Features Investigated in Proteogenomic Studies
Two independent research teams turned to proteogenomics to parse out the transition from pre-invasive to invasive lung adenocarcinoma and to assess small cell lung cancer.
Tempus, AstraZeneca Collaborate on Response Biomarker Discovery for Small Cell Lung Cancer
This clinical study, called Sculptor, is the first research to emerge from a strategic collaboration between the companies on oncology therapeutics.
Small Cell Lung Cancer Detection, Classification Achieved Using Cell-Free DNA Methylation
With a bisulfite-free sequencing method, researchers showed that they could identify and characterize SCLC based on circulating cell-free tumor DNA in blood samples.
Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib
The NGS firm will work with Impact to develop companion diagnostics to select patients eligible for Impact's synthetic lethality drugs, beginning with senaparib.